Publications by authors named "Francesca Maria Gaiani"

Claim this Profile
C
Cumulative clinical benefits of biologic treatments in patients with moderate-to-severe psoriasis: an Italian real-life experience - IL PSO (Italian Landscape Psoriasis).
Diego Orsini, Luca Potestio, Maria Concetta Fargnoli, Alessandra Narcisi, Luciano Ibba, Francesca Maria Gaiani

Clin Exp Dermatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The risk of candidiasis during treatment with bimekizumab for the management of plaque psoriasis: a 16-week multicentre real-world experience - IL PSO (Italian Landscape Psoriasis).
Matteo Megna, Diego Orsini, Chiara Assorgi, Anna Balato, Riccardo Balestri, Francesca Maria Gaiani

Clin Exp Dermatol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Efficacy of the HIV Protease Inhibitor Indinavir in Combination with Chemotherapy for Advanced Classic Kaposi Sarcoma Treatment: A Single-Arm, Phase II Trial in the Elderly.
Cecilia Sgadari, Biancamaria Scoppio, Orietta Picconi, Antonella Tripiciano, Francesca Maria Gaiani

Cancer Res Commun· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness, Tolerability, and Drug Survival of Risankizumab in a Real-World Setting: A Three-Year Retrospective Multicenter Study-IL PSO (ITALIAN LANDSCAPE PSORIASIS).
Luigi Gargiulo, Luciano Ibba, Piergiorgio Malagoli, Fabrizio Amoruso, Giuseppe Argenziano, Francesca Maria Gaiani

J Clin Med· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Palmoplantar pustulosis successfully treated with upadacitinib: Report of three cases.
Francesca Maria Gaiani, Piergiorgio Malagoli, Carlo Giovanni Carrera

Australas J Dermatol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brodalumab for the treatment of plaque psoriasis in a real-life setting: a 3 years multicenter retrospective study-IL PSO (Italian landscape psoriasis).
Luigi Gargiulo, Luciano Ibba, Piergiorgio Malagoli, Fabrizio Amoruso, Giuseppe Argenziano, Francesca Maria Gaiani

Front Med (Lausanne)· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-life effectiveness and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: A 104-week multicenter retrospective study - IL PSO (ITALIAN LANDSCAPE PSORIASIS).
Luigi Gargiulo, Luciano Ibba, Piergiorgio Malagoli, Rosa Giuseppa Angileri, Federico Bardazzi, Francesca Maria Gaiani

J Eur Acad Dermatol Venereol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world evidence of biologic treatments in moderate-severe psoriasis in Italy: Results of the CANOVA (EffeCtiveness of biologic treAtmeNts for plaque psOriasis in Italy: An obserVAtional longitudinal study of real-life clinical practice) study.
Delia Colombo, Luca Bianchi, Gabriella Fabbrocini, Salvatore Corrao, Annamaria Offidani, Francesca Maria Gaiani

Dermatol Ther· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Secukinumab Exhibits Sustained and Stable Response in Patients with Moderate-to-Severe Psoriasis: Results from the SUPREME Study.
Antonio Costanzo, Filomena Russo, Marco Galluzzo, Luca Stingeni, Roberta Scuderi, Francesca Maria Gaiani

Acta Derm Venereol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A real-world economic analysis of biologic therapies for moderate-to-severe plaque psoriasis in Italy: results of the CANOVA observational longitudinal study.
Emanuela Zagni, Luca Bianchi, Gabriella Fabbrocini, Salvatore Corrao, Annamaria Offidani, Francesca Maria Gaiani

BMC Health Serv Res· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Secukinumab demonstrates improvements in absolute and relative psoriasis area severity indices in moderate-to-severe plaque psoriasis: results from a European, multicentric, retrospective, real-world study.
Andrea Chiricozzi, Anna Balato, Curdin Conrad, Andrea Conti, Paolo Dapavo, Francesca Maria Gaiani

J Dermatolog Treat· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis